US 12,226,222 B2
Wireless active monitoring implant system
Estefania Alvarez, West Newton, MA (US)
Assigned to Hologic, Inc., Marlborough, MA (US)
Filed by Hologic, Inc., Marlborough, MA (US)
Filed on Sep. 11, 2023, as Appl. No. 18/464,441.
Application 18/464,441 is a continuation of application No. 16/647,293, granted, now 11,877,857, previously published as PCT/US2018/050174, filed on Sep. 10, 2018.
Claims priority of provisional application 62/558,034, filed on Sep. 13, 2017.
Prior Publication US 2024/0065614 A1, Feb. 29, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. A61B 5/00 (2006.01); A61B 5/1468 (2006.01); G16H 20/10 (2018.01); G16H 50/20 (2018.01)
CPC A61B 5/4312 (2013.01) [A61B 5/0022 (2013.01); A61B 5/1468 (2013.01); A61B 5/4842 (2013.01); A61B 5/4848 (2013.01); A61B 5/6867 (2013.01); A61B 5/74 (2013.01); G16H 20/10 (2018.01); G16H 50/20 (2018.01); A61B 2560/0219 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A method of detecting data related to a human body, the method comprising:
detecting data related to the human body at a biosensor disposed in a breast cavity in real-time, wherein the data comprises one or more biochemical parameters;
transmitting the data to an external monitoring device located outside of the breast;
receiving feedback from the external monitoring device, wherein the feedback relates to the transmitted data and anatomical measurements related to a portion of the breast adjacent the breast cavity, the anatomical measurements comprising at least one of diameter, length, phenotype, and lesion distribution;
based on the feedback, adjusting a set of biochemical parameters to be monitored; and
monitoring the adjusted set of biochemical parameters to modify a cancer treatment.